EP Patent

EP3284494A1 — Portable infusion pump system

Assigned to Tandem Diabetes Care Inc · Expires 2018-02-21 · 8y expired

What this patent protects

The invention relates to a portable infusion pump system, comprising a processor and a touch-screen display.

USPTO Abstract

The invention relates to a portable infusion pump system, comprising a processor and a touch-screen display.

Drugs covered by this patent

Zolinza (VORINOSTAT) · Merck & Co.

Patent Metadata

Patent number: EP3284494A1
Jurisdiction: EP
Classification: —
Expires: 2018-02-21
Drug substance claim: No
Drug product claim: No
Assignee: Tandem Diabetes Care Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.